| Kroger Pharmacy 320 | |
| 1745 Highway 138 Se, Ste 138, Conyers, Georgia 30013 | |
| (770) 922-0447 |
| Name | Kroger Pharmacy 320 |
|---|---|
| Organization Name | The Kroger Co |
| Location | 1745 Highway 138 Se, Ste 138, Conyers, Georgia 30013 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (770) 922-0447 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Osiris Therapeutics, Inc., today provided an update on the status of the development and commercialization agreement with Genzyme, a Sanofi company.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Kaiser Health News staff writers Mary Agnes Carey and Phil Galewitz write about last night's big news. "In one of the most anticipated events in the health reform debate, Majority Leader Harry Reid, D-Nev., tonight released the bill expected to go to the Senate floor. Reid added new taxes and modified major provisions of health bills passed by two Senate panels in his quest to meet President Barack Obama's target of health legislation that would cost less than $900 billion and win 60 votes in the Senate" (11/18).
The Associated Press: While President Barack Obama "has set a high priority on battling health care fraud and waste" in Medicare, private contractors are slow in referring cases to law enforcement. "According to congressional investigators, the exact average was 178 days [to refer the case for prosecution].
Scientists at The Scripps Research Institute have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
› Verified 8 days ago
| NPI Number | 1598799322 |
| Organization Name | THE KROGER CO |
| Doing Business As | KROGER PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1745 Highway 138 Se, Conyers, GA 30013 |
| Phone Number | 770-922-0447 |
News Archive
Osiris Therapeutics, Inc., today provided an update on the status of the development and commercialization agreement with Genzyme, a Sanofi company.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Kaiser Health News staff writers Mary Agnes Carey and Phil Galewitz write about last night's big news. "In one of the most anticipated events in the health reform debate, Majority Leader Harry Reid, D-Nev., tonight released the bill expected to go to the Senate floor. Reid added new taxes and modified major provisions of health bills passed by two Senate panels in his quest to meet President Barack Obama's target of health legislation that would cost less than $900 billion and win 60 votes in the Senate" (11/18).
The Associated Press: While President Barack Obama "has set a high priority on battling health care fraud and waste" in Medicare, private contractors are slow in referring cases to law enforcement. "According to congressional investigators, the exact average was 178 days [to refer the case for prosecution].
Scientists at The Scripps Research Institute have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
› Verified 8 days ago
News Archive
Osiris Therapeutics, Inc., today provided an update on the status of the development and commercialization agreement with Genzyme, a Sanofi company.
Drug discovery and development company Esperance Pharmaceuticals today announced that it has begun enrollment and dosing of patients in a Phase 1 study of EP-100 in patients with advanced solid tumors. EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP(TM)) platform technology, is a targeted membrane-disrupting peptide (tMDP) designed to seek and destroy cancer cells that over-express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Kaiser Health News staff writers Mary Agnes Carey and Phil Galewitz write about last night's big news. "In one of the most anticipated events in the health reform debate, Majority Leader Harry Reid, D-Nev., tonight released the bill expected to go to the Senate floor. Reid added new taxes and modified major provisions of health bills passed by two Senate panels in his quest to meet President Barack Obama's target of health legislation that would cost less than $900 billion and win 60 votes in the Senate" (11/18).
The Associated Press: While President Barack Obama "has set a high priority on battling health care fraud and waste" in Medicare, private contractors are slow in referring cases to law enforcement. "According to congressional investigators, the exact average was 178 days [to refer the case for prosecution].
Scientists at The Scripps Research Institute have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
› Verified 8 days ago
Able Prosthetic Care Inc Type: Prosthetic/Orthotic Supplier Location: 2141 Eastview Pkwy, Conyers, Georgia 30013 Phone: (770) 922-5540 | |
Analia Home Healthcare Services Llc Type: Medicare Supplier Location: 2365 Wall St Se, Conyers, Georgia 30013 Phone: (404) 587-0945 | |
Apria Healthcare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 329 Gees Mill Business Pkwy Ne, Conyers, Georgia 30013 Phone: (770) 761-6706 | |
Beasley Drug Company Type: Community/Retail Pharmacy Location: 933 Center St Ne, Conyers, Georgia 30012 Phone: (770) 483-7211 | |
C H Martin Company Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2395 Wall Street, Conyers, Georgia 30013 Phone: (770) 761-7668 |